TGFB1 and IL10 polymorphisms were associated with developing EBV-positive PTLD in a candidate gene study of 38 late-onset PTLD cases and 400 PTLD-free solid organ transplant recipients [69]. Here, TGFB1 is linked to post-transplant lymphoproliferative disease.